Streetbeat News

Products Services

MSFT

Microsoft's new AI model, Phi-4, outperforms larger competitors like Google's Gemini Pro with superior mathematical reasoning while using fewer resources, signaling a revolutionary shift in AI development.

Portfolio Pulse from

December 13, 2024 | 2:30 am

HYMTF

Hyundai Motor Group Innovation Center Singapore (HMGICS) celebrated its first anniversary, highlighting its role in advancing Hyundai's sustainable mobility vision. Executive Chair Euisun Chung emphasized HMGICS's strategic importance in Hyundai's future mobility solutions.

Portfolio Pulse from

December 13, 2024 | 2:15 am

AVGO

Broadcom's projections for 2027 highlight the expanding AI boom in semiconductors beyond Nvidia, though risks remain in its forecast.

Portfolio Pulse from

December 13, 2024 | 1:30 am

LOOP

Loop Industries has secured a €10 million investment from Reed Societe Generale Group through a convertible preferred security at a $4.75 conversion price. Additionally, Loop has completed its first sale of an Infinite Loop technology license, generating an upfront payment of €10 million.

Portfolio Pulse from

December 13, 2024 | 1:30 am

COST

Costco's digital transformation is driving growth, with digital sales outpacing overall growth. The company's Q3 fiscal 2025 results show strong online and in-store performance.

Portfolio Pulse from

December 13, 2024 | 1:00 am

GOOG

Google has launched a new Android operating system specifically for extended reality (XR) devices, developed in collaboration with Samsung. The first devices to use this system will be Samsung's Project Moohan headsets.

Portfolio Pulse from

December 13, 2024 | 12:45 am

BGNE

BeiGene, Ltd. has entered a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology for SYH2039, a MAT2A inhibitor targeting solid tumors with MTAP deletion. BeiGene plans to change its name to BeOne Medicines Ltd.

Portfolio Pulse from

December 13, 2024 | 12:45 am

META

Meta has announced the release of an AI model named Meta Motivo, designed to control the movements of digital agents, potentially enhancing the Metaverse experience.

Portfolio Pulse from

December 13, 2024 | 12:30 am

HCM

TAK

HUTCHMED will receive a $10 million milestone payment from Takeda following the first European reimbursement for FRUZAQLA® (fruquintinib), a novel oral therapy for metastatic colorectal cancer. This follows its European approval in June 2024.

Portfolio Pulse from

December 13, 2024 | 12:15 am

BIOA

Levi & Korsinsky has initiated an investigation into BioAge Labs, Inc. (NASDAQ:BIOA) for potential violations of federal securities laws following the discontinuation of its STRIDES Phase 2 trial due to safety concerns.

Portfolio Pulse from

December 13, 2024 | 12:15 am